z-logo
open-access-imgOpen Access
Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010–2017
Author(s) -
Hugh Adler,
Elissavet Nikolaou,
Katherine A. Gould,
Jason Hinds,
Andrea M. Collins,
Victoria Connor,
Caz Hales,
Helen Hill,
Angela Hyder-Wright,
Seher Zaidi,
Esther L. German,
Jenna F. Gritzfeld,
Elena Mitsi,
Sherin Pojar,
Stephen B. Gordon,
Adam P. Roberts,
Jamie Rylance,
Daniela M. Ferreira
Publication year - 2019
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiz034
Subject(s) - colonization , serotype , medicine , streptococcus pneumoniae , antibiotics , pneumococcal conjugate vaccine , microbiology and biotechnology , virology , biology
Pneumococcal colonization is rarely studied in adults, except as part of family surveys. We report the outcomes of colonization screening in healthy adults (all were nonsmokers without major comorbidities or contact with children aged <5 years) who had volunteered to take part in clinical research. Using nasal wash culture, we detected colonization in 6.5% of volunteers (52 of 795). Serotype 3 was the commonest serotype (10 of 52 isolates). The majority of the remaining serotypes (35 of 52 isolates) were nonvaccine serotypes, but we also identified persistent circulation of serotypes 19A and 19F. Resistance to at least 1 of 6 antibiotics tested was found in 8 of 52 isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom